Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
about
Evolutionary medicine and chronic inflammatory state--known and new concepts in pathophysiologyChronic inflammatory systemic diseases: An evolutionary trade-off between acutely beneficial but chronically harmful programsNew pharmacological strategies in rheumatic diseasesT-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significanceHost susceptibility to persistent hepatitis B virus infectionAssociation of the Co-stimulatory Molecules Polymorphisms with CMV Infection in Liver Transplant RecipientsPolymorphisms in programmed death-1 gene are not associated with chronic HBV infection in Chinese patients.Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern ChineseAge-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiotaRole of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease.Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistenceNo association between IRF3 polymorphism and susceptibility to hepatitis B virus infection in Chinese patientsInfluence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade.Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantationGenetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China.Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.Association of CTLA4 gene polymorphisms with susceptibility and pathology correlation to pulmonary tuberculosis in Southern Han ChineseA pilot study on cytotoxic T lymphocyte-4 gene polymorphisms in urinary schistosomiasisQuantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development.Association of GNLY genetic polymorphisms with chronic liver disease in a Korean population.CTLA4 autoimmunity-associated genotype contributes to severe pulmonary tuberculosis in an African population.Relationship between interleukin-6 polymorphism and susceptibility to chronic hepatitis B virus infection.The Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes.PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention.Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response.The impact of biologic response modifiers on hepatitis B virus infection.Association of variants in HLA-DP on chromosome 6 with chronic hepatitis B virus infection and related phenotypes.Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection.Association between the HLA-DQB1 polymorphisms and the susceptibility of chronic hepatitis B: A comprehensive meta-analysis.Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to chronic hepatitis B.A promoter polymorphism (rs3806798) of interleukin-15 gene is associated with chronic hepatitis B virus infection in the Chinese Han population.Association between cytotoxic T-lymphocyte associated protein 4 gene +49 A/G polymorphism and chronic infection with hepatitis B virus: a meta-analysis.Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients.Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12.Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection.Associations between cytotoxic T lymphocyte-associated antigen-4 polymorphisms and serum tumor necrosis factor-α and interferon-γ levels in patients with chronic hepatitis B virus infection.Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection.
P2860
Q24620087-5FAAD66C-B9C1-435F-9D0F-13AE8AC0E515Q26773455-3C0CECE6-B085-4714-AA91-47DBD4F32684Q28073763-CFE28A9C-02FA-407D-8028-55F3D7342831Q28083810-0F7E9FF2-5A0F-4367-BC7A-F367A3570558Q33866976-24290CFB-C941-4C3F-8732-1319CE5A1184Q33871825-A13E82D4-2438-482E-994F-E34D65AB7CA6Q34779172-6CB59A30-3D0A-46E0-AFE2-182FD1495988Q34794443-2BA1F0E6-A54D-4924-BB74-E697D1C4AC2CQ35129064-64EACF94-276B-452D-A824-91422FB4819AQ35208006-B03B5A70-5C4A-49C6-922D-388ABE334C7CQ35237316-CDE18894-6970-46A1-BAFC-7B84537E187AQ35634901-45D7FFC3-3F4C-4E95-8EC2-23B192534E58Q35681541-7F4C239F-B06F-4B1D-A54F-A1B6A0672DD6Q35747554-4F14A745-A862-4AFE-9496-47FE75E7D048Q35760507-886D14D0-6D23-4D69-A725-5FE7AC6811E5Q36025479-E854DA22-E59A-40DA-A600-98952F6D44F2Q36067577-AFC00804-F28D-41C0-9427-7DAAB5275BDFQ36101961-B373CE08-4192-4DB2-94BD-7FBE9BB3CF86Q36117526-D0B0346F-0BF9-4FB9-BE7D-84FD015ACA07Q36158905-E43D6AEC-6461-476E-9F2C-98FF7EBDCD4FQ36194159-83AC2A45-AA5F-4254-83DB-1B2E6F086934Q37254718-0E22478C-6AD2-4DEB-A3D0-A6C87426A275Q37266440-59CD8D99-9137-4D70-AC71-A0DD3739A64CQ37361121-CC58A10A-A0EE-4F2C-93EA-58B4384435ADQ37469795-4AF0314B-1B6C-45F0-8ACB-C4BC0D41088CQ37798839-BAAEAEA4-045F-46BA-AAFB-BD41962F1D91Q37832503-7D437C80-636C-48E3-9F80-94E55D278173Q38213316-347CD478-5358-4575-99F0-D349DB4B3768Q38634826-66D44B4A-63E6-4649-BCE7-35B01692C644Q39432561-30149590-0150-4C69-811A-D2C0E00D7DB9Q40336301-9486C8AF-9394-4F76-8C31-CBB98B53F97DQ40482705-234237FB-4FC3-4E03-9A19-74ED2E521445Q40975207-275368F9-76A4-4B41-826A-4F807FFA9963Q42222531-81AE567A-39D9-4756-B093-FACEBFE5394CQ42263268-6AF0782E-F2A8-4C6C-A602-19DAD436679EQ42267746-9AAD2738-C9DB-46FA-8BD7-F59DE59493E6Q43173401-E63F49AC-49C3-4C96-A96E-6C0CA5E1069BQ44149675-BC3548B6-18A1-49AE-8FC2-A0EC2D653487Q45364079-BF255950-86EA-4133-B342-EBD37138590EQ45368686-7C5BCCC3-3E4C-49E8-91F7-74F6D3DC3E32
P2860
Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
@en
Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
@nl
type
label
Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
@en
Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
@nl
prefLabel
Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
@en
Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
@nl
P2093
P2860
P1433
P1476
Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection
@en
P2093
Chloe L Thio
David L Thomas
Jacquie Astemborski
Richard A Kaslow
Steffanie A Strathdee
Stephen J O'Brien
Timothy L Mosbruger
P2860
P304
11258-11262
P356
10.1128/JVI.78.20.11258-11262.2004
P407
P577
2004-10-01T00:00:00Z